source
- Legend Biotech CEO Ying Huang resigns, interim leader Alan Bash appointedLegend Biotech announced that its chief executive, Ying Huang, Ph.D., stepped down on Friday, with no permanent successor named yet. The board named Alan Bash as interim CEO on July 23, according…
- Upcoming Q2 earnings from Moderna, AstraZeneca, GSK and others highlighted in weekly pharma previewThe Endpoints Weekly newsletter signals a busy earnings week for major pharmaceutical companies, with Q2 results slated from Moderna, AstraZeneca, GSK, Bristol Myers Squibb and several others. It…